Tag: cost-effective
One-year snapshot shows cost benefits for prostate artery embolization over gold...
Prostate artery embolization (PAE) is more cost-effective than transurethral resection of the prostate (TURP), the gold standard for the management of patients with benign...
ConvertX nephroureteral stent system gets US FDA clearance
BrightWater Medical has announced that the US FDA has cleared the company’s innovative ConvertX nephroureteral stent system for treatment of ureteral obstructions.
Patients with...